Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Light Still On For Switches After Pfizer Pulls Plug On OTC Lipitor

This article was originally published in The Tan Sheet

Executive Summary

A 1,200-subject actual use trial to simulate the OTC use of Lipitor 10 mg did not meet its primary objectives of demonstrating patient compliance with the direction to check low-density lipoprotein cholesterol level and after checking their LDL-C level take appropriate action based on test results.


Related Content

Pfizer Mum On Consumer Business Plans As Analysts Say Spin-off
Pfizer Déjà Vu: Is It Time To Sell The Consumer Health Business?
Pfizer Déjà Vu: Is It Time To Sell The Consumer Health Business?
Perrigo’s Outgoing CEO Advocates OTC Switches, Starting With Statins
OTC Switch Interest Cooled By Study Costs To Update Safety Data
Perrigo OTC Growth Rides Innovation Path Wider Than Switches
FDA's OTC Naloxone Study Is A Starting Point For Other Switches, Not A Roadmap
Consumer Business An Asset To Pfizer, A Divestment Chip To Analysts
Pfizer Keeps Hands On Consumer Product Wheel In Opting Against Split
Naloxone Costs Could Temper Non-Rx Access Even As Distribution Spreads


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts